Homology Medicines announced that it received notification from Nasdaq indicating that, for the last thirty consecutive business days, the bid price for the company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Select Market.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FIXX: